Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

Toward a Common Research Agenda in Infection-Associated Chronic Illnesses: Proceedings of a Workshop

National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Board on Global Health; Forum on Neuroscience and Nervous System Disorders; Forum on Microbial Threats
Megan Snair, Julie Liao, Elizabeth Ashby, Claire Biffl
, editors.
Washington (DC): National Academies Press (US); 2024 Apr 3.
The National Academies Collection: Reports funded by National Institutes of Health.
Free Books & Documents
Review

Toward a Common Research Agenda in Infection-Associated Chronic Illnesses: Proceedings of a Workshop

National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Board on Global Health; Forum on Neuroscience and Nervous System Disorders; Forum on Microbial Threats.
Free Books & Documents

Excerpt

The National Academies Forum on Microbial Threats and Forum on Neuroscience and Nervous System Disorders hosted a hybrid public workshop in June 2023 to explore opportunities to advance research and treatment of infection-associated chronic illnesses. The illnesses discussed in this workshop, including COVID-19, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), persistent or posttreatment Lyme disease syndrome (PTLDS), and multiple sclerosis (MS), share overlapping mechanisms and symptoms and have been inadequately researched. Recognizing these commonalities, speakers identified the need to advance research more comprehensively, translating to improved diagnostic and treatment options for patients across multiple conditions.

PubMed Disclaimer

Grants and funding

National Academy of Sciences and the American Society of Tropical Medicine and Hygiene; Burroughs Wellcome Fund (Contract No. 1022390); EcoHealth Alliance; Infectious Diseases Society of America; Johnson & Johnson (Contract No. C2022024120); Merck and Co. (Grant No. MEM-22-160471); National Center of Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (Contract No. 75D30121D11240, Order No. 75D30122F00011); National Institute of Allergy and Infectious Diseases, National Institutes of Health (Contract No. HHSN263201800029I, Task Order No. HHSN26300011); New Venture Fund (Grant No. NVF-NGDF-NAT10-Subgrant-022263-2023-08-01); Rockefeller Foundation; Sanofi Pasteur; the Society of Infectious Diseases Pharmacists; Steven & Alexandra Cohen Foundation (Award No. Lyme 76); Uniformed Services University of Health Sciences (Award No. HU00012210001); U.S. Agency for International Development (Grant No. 7200AA18GR00003); U.S. Department of Veterans Affairs (Contract No. 36C25022Q1147); and U.S. Food and Drug Administration (Award No. 5R13FD006897-03). Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project.

LinkOut - more resources